Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Alivus Life Sciences Ltd.
NSE: ALIVUS
|
BSE: 543322
|
ISIN: INE03Q201024
|
Industry: Pharmaceuticals
Board Meeting
|
Expensive Performer
1206.0000
25.10
(
2.13
%)
NSE
May 15, 2025
15:52 PM
59.53% Gain from 52W Low
Volume:
110.8K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alivus Life Sciences Ltd.
29 Apr 2024
Board Meeting
1206.00
2.13%
Glenmark Life Science
Buy:
Alivus Life Sciences Ltd.
by
ICICI Direct
Target: 1040
ICICI Direct
Alivus Life Sciences Ltd. is trading above all available SMAs
More from Alivus Life Sciences Ltd.
Recommended
Market closes higher, Saregama India's Q4 net profit grows 11.8% YoY to Rs 60.1 crore
Trendlyne Marketwatch |
15 May 2025, 04:06PM
A car running on flat tires: Pakistan's economy is struggling
The Baseline |
15 May 2025, 09:48AM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
|
27 Jul 2021